ADHD
499
60
77
302
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
82 trials with published results (16%)
Research Maturity
302 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.8%
14 terminated out of 499 trials
95.6%
+9.0% vs benchmark
19%
96 trials in Phase 3/4
27%
82 of 302 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 302 completed trials
Clinical Trials (499)
Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)
Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder
Network Analysis of Adult MDD and ADHD
Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI
A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Benefits of ADHD Treatment in Detained People
Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD
QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)
Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
Rapid Entrainment and Signal-guided Neuromodulation for Behavioral Health
Fidgeting and Attentional and Emotional Regulation in ADHD
Developing Microbiome and Dietary Strategies Based on Chrono-nutrition for Targeting ADHD
A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD
Personalising ADHD Medication Treatment for Children and Young People
ADHD and Mental Effort
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems